Parameswaran Hari reports a stock award at OBX
By AlphaYouPublished Form 4
Hari Parameswaran
Reporting filer
Parameswaran Hari reports a stock award, not an open-market purchase or sale, in Obsidian Therapeutics, Inc.. Form 4 filed Nov 13, 2026 lists 1 entry.
- Disclosed
- Nov 13, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | Hari Parameswaran | 2026-08-03 | A | Grant or award | 331173 | 0 | 331,173 | 102 days | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- Hari Parameswaran
- Date
- 2026-08-03
- Code
- A
- Action
- Grant or award
- Quantity
- 331173
- Price
- 0
- Following holdings
- 331,173
- Reporting delay
- 102 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 12
- transaction Date: 2026-08-03
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 331173
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-08-02
- underlying Security Title: Common Stock
- underlying Security Shares: 331173
- shares Owned Following Transaction: 331173
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Hari Parameswaran: Chief Medical Officer.
- F1: The shares underlying this option shall vest and become exercisable in sixteen (16) equal quarterly installments following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.